Sanofi (EPA:SAN)
France
· Delayed Price · Currency is EUR 90.71
+0.32 (0.35%)
Apr 17, 2025, 5:39 PM CET
Sanofi Revenue
In the year 2024, Sanofi had annual revenue of 44.29B EUR with 7.73% growth. Sanofi had revenue of 11.42B in the quarter ending December 31, 2024.
Revenue
44.29B
Revenue Growth
+7.73%
P/S Ratio
2.51
Revenue / Employee
534.35K
Employees
82,878
Market Cap
111.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
| Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
| Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sartorius Stedim Biotech | 2.78B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.43B |
| Clariane SE | 5.28B |
Sanofi News
- 8 hours ago - Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition - Reuters
- 8 hours ago - Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria - GlobeNewsWire
- 1 day ago - Earendil Labs and Sanofi partner for two bispecific antibodies - Seeking Alpha
- 3 days ago - Sanofi Asthma Drug Misses Primary Goal, Plans For Pivotal Study - Benzinga
- 3 days ago - Sanofi flunks mid-stage trial for asthma drug - Seeking Alpha
- 3 days ago - Press Release: Sanofi's respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD - Benzinga
- 3 days ago - Press Release: Sanofi's respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD - GlobeNewsWire
- 8 days ago - How Do Investors Really Feel About Sanofi? - Benzinga